.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Covington
QuintilesIMS
Queensland Health
Baxter
Johnson and Johnson
Deloitte
Daiichi Sankyo
Fuji
Boehringer Ingelheim

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,263,550

« Back to Dashboard

Details for Patent: 8,263,550

Title:Exendin agonist compounds
Abstract: Novel exendin agonist compounds are provided. These compounds are useful in treating Type I and II diabetes and conditions which would benefit by lower plasma glucose and delaying and/or slowing gastric emptying.
Inventor(s): Beeley; Nigel Robert Arnold (San Diego, CA), Prickett; Kathryn S. (Foster City, CA)
Assignee: Amylin Pharmaceuticals, Inc. (San Diego, CA)
Filing Date:Dec 02, 2010
Application Number:12/959,176
Claims:1. A compound comprising the amino acid sequence of Formula (II): TABLE-US-00007 Xaa.sub.1 Xaa.sub.2 Xaa.sub.3 Gly Thr Xaa.sub.4 Xaa.sub.5 Xaa.sub.6 Xaa.sub.7 Xaa.sub.8 Ser Lys Gln Xaa.sub.9 Glu Glu Glu Ala Val Arg Leu Xaa.sub.10 Xaa.sub.11 Xaa.sub.12 Xaa.sub.13 Leu X.sub.1 Gly Gly Xaa.sub.14 Ser Ser Gly Ala Xaa.sub.15 Xaa.sub.16 Xaa.sub.17 Xaa.sub.18-Z;

wherein: Xaa.sub.1 4-imidazopropionyl; Xaa.sub.2 is Ser, Gly, Ala or Thr; Xaa.sub.3 is Asp or Glu; Xaa.sub.4 is Phe, Tyr or naphthylalanine; Xaa.sub.5 is Thr or Ser; Xaa.sub.6 is Ser or Thr; Xaa.sub.7 is Asp or Glu; Xaa.sub.8 is Leu, Ile, Val, pentylglycine or Met; Xaa.sub.9 is Leu, Ile, pentylglycine, Val or Met; Xaa.sub.10 is Phe, Tyr or naphthylalanine; Xaa.sub.11 is Ile, Val, Leu, pentylglycine, tert-butylglycine or Met; Xaa.sub.12 is Glu or Asp; Xaa.sub.13 is Trp, Phe, Tyr, or naphthylalanine; X.sub.1 is Lys Asn, Asn Lys, Lys-NH.sup.e-R Asn, or Asn Lys-NH.sup.e-R where R is Lys, Arg, C.sub.1-C.sub.10 straight chain or branched alkanoyl or cycloalkyanoyl; Xaa.sub.14, Xaa.sub.15, Xaa.sub.16 and Xaa.sub.17 are independently Pro, homoproline, 3Hyp, 4Hyp, thioproline, N-alkylglycine, N-alkylpentylglycine or N-alkylalanine; Xaa.sub.18 is Ser, Thr or Tyr; and Z is --OH or --NH.sub.2; with the proviso that the compound does not have the formula of SEQ ID. NO:1 or 2.

2. The compound of claim 1, wherein: Xaa.sub.2 is Gly; Xaa.sub.3 is Glu; Xaa.sub.4 is Phe; Xaa.sub.5 is Thr; Xaa.sub.6 is Ser; Xaa.sub.7 is Asp; Xaa.sub.8 is Leu; Xaa.sub.9 is Leu or Met; Xaa.sub.10 is Phe; Xaa.sub.11 is Ile; Xaa.sub.12 is Glu; Xaa.sub.13 is Trp or Phe; X.sub.1 is Lys Asn; Xaa.sub.14, Xaa.sub.15, Xaa.sub.16 and Xaa.sub.17 are independently Pro; Xaa.sub.18 is Ser; and Z is --NH.sub.2.

3. The compound of claim 2, wherein Xaa.sub.9 is Met and Xaa.sub.13 is Trp.

4. The compound of claim 2, wherein Xaa.sub.9 is Len.

5. The compound of claim 4, wherein Xaa.sub.9 is Len and Xaa.sub.13 is Phe.

6. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 1 and a pharmaceutically acceptable carrier.

7. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 2 and a pharmaceutically acceptable carrier.

8. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 3 and a pharmaceutically acceptable carrier.

9. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 4 and a pharmaceutically acceptable carrier.

10. A pharmaceutical composition comprising a therapeutically effective amount of the compound of claim 5 and a pharmaceutically acceptable carrier.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Dow
Moodys
Fish and Richardson
Julphar
Daiichi Sankyo
Cipla
Farmers Insurance
McKesson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot